Stada Arzneimittel AG operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Stada Arzneimittel AG with three other
pharmaceutical manufacturers in Europe:
sales of 1.67 billion Euro [US$1.80 billion]
Hikma Pharmaceuticals PLC
of the United Kingdom
(£1.45 billion [US$1.81 billion]
H. Lundbeck A/S
based in Denmark
(15.63 billion Danish Kroner [US$2.27 billion]
of which 19%
was Other Pharmaceuticals).
Stada Arzneimittel AG reported sales of 2.15 billion Euro (US$2.32 billion)
December of 2016.
a very small
increase of 1.7%
versus 2015, when the company's sales were 2.12 billion Euro.
Sales at Stada Arzneimittel AG have increased during each of the previous five years
(and since 2011, sales have increased a total of 25%).